课题基金 / 基金详情

Comparative studies of a clinical features and genomic analysis in patients with interstitial lung disease and drug induced lung injury

Comparative studies of a clinical features and genomic analysis in patients with interstitial lung disease and drug induced lung injury
间质性肺疾病和药物性肺损伤患者临床特征和基因组分析的比较研究
批准号:
19390224
负责人:
KOHNO Nobuoki
金额:
$12.06万
依托单位:
依托单位国家:
日本
项目类别:
Grant-in-Aid for Scientific Research (B)
财政年份:
2007
资助国家:
日本
项目状态:
已结题
起止时间:
2007 至 2009

项目摘要

项目成果

KOHNO Nobuoki的其他基金

相似基金

相关文献

中文摘要
翻译
我们通过与德国的国际合作研究阐明了间质性肺疾病(ILD)的种族差异。欧洲健康志愿者血清KL-6水平显著高于日本人。另一方面,欧洲ILD患者血清KL-6水平不显著高于日本。欧洲特发性间质性肺炎(IIP)患者血清KL-6水平显著高于欧洲对照组,且与某些肺功能检查和BALF结果呈负相关。微阵列分析显示基因表达模式明显区分IIP和慢性超敏性肺炎。
英文摘要
We elucidate a racial difference of the interstitial lung disease (ILD) by international collaborative investigation with Germany. The serum levels of KL-6 in European healthy volunteers were significantly higher than Japanese. On the other hands, serum levels of KL-6 in European ILD patients were not significantly higher than Japanese. Serum levels of KL-6 in European patients with idiopathic interstitial pneumonia (IIP) were significantly higher than European controls, and were correlated with inversely with some pulmonary function tests and BALF findings. Microarray analysis revealed that gene expression patterns clearly distinguished IIP from chronic hypersensitivity pneumonia.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Genetic ablation of Bach 1 gene reduces hyperoxic lung injury in mice : role of IL-6 article type
Bach 1 基因的基因消融可减少小鼠高氧性肺损伤:IL-6 的作用 Article Type
DOI: --
发表时间: 2009
期刊: Free Radical Biology & Medicine 46
影响因子: --
作者: [Wang Z, Iwasaki Y, Zhao LF, Nishiyama M, Taguchi T, Tsugita M, Kambayashi M, Hashimoto K, Terada Y, Tanimoto T]
通讯作者: Tanimoto T
DOI: 10.1016/j.bbrc.2006.12.128
发表时间: 2007-02
期刊: Biochemical and biophysical research communications
影响因子: 3.1
作者: [Hiroyasu Shoda;A. Yokoyama;Ryouhei Nishino;Taku Nakashima;N. Ishikawa;Y. Haruta;N. Hattori;T. Naka;N. Kohno]
通讯作者: Hiroyasu Shoda;A. Yokoyama;Ryouhei Nishino;Taku Nakashima;N. Ishikawa;Y. Haruta;N. Hattori;T. Naka;N. Kohno
KL-6の発見から臨床応用まで
从KL-6的发现到临床应用
DOI: --
发表时间: 2008
期刊:
影响因子: --
作者: [香川亨, 寺田典生, 河野修興]
通讯作者: 河野修興
DOI: 10.1002/pmic.200800374
发表时间: 2009-04
期刊: PROTEOMICS
影响因子: 3.4
作者: [K. Ueda;Y. Fukase;T. Katagiri;N. Ishikawa;S. Irie;Takashi Sato;H. Ito;H. Nakayama;Y. Miyagi;E. Tsuchiya;N. Kohno;M. Shiwa;Yusuke Nakamura;Y. Daigo]
通讯作者: K. Ueda;Y. Fukase;T. Katagiri;N. Ishikawa;S. Irie;Takashi Sato;H. Ito;H. Nakayama;Y. Miyagi;E. Tsuchiya;N. Kohno;M. Shiwa;Yusuke Nakamura;Y. Daigo
43
    Anti KL-6 antibody enhances the effects of molecular targeted drug
    • 批准号:
      23659433
    • 项目类别:
      Grant-in-Aid for Challenging Exploratory Research
    • 资助金额:
      $2.25万
    • 财政年份:
      2011
    • 负责人:
      KOHNO Nobuoki
    • 依托单位:
    The Study on KL-6 as Morbidity Ornamentation Factor and Prognosis Factor of Idiopathic Interstitial Pneumonia.
    • 批准号:
      14370197
    • 项目类别:
      Grant-in-Aid for Scientific Research (B)
    • 资助金额:
      $8.83万
    • 财政年份:
      2002
    • 负责人:
      KOHNO Nobuoki
    • 依托单位:
    The Establishment of KL-6 Associated New Serum Markers Using High Sensitive Electrochemiluminescence Immunoassay.
    • 批准号:
      13557051
    • 项目类别:
      Grant-in-Aid for Scientific Research (B)
    • 资助金额:
      $9.02万
    • 财政年份:
      2001
    • 负责人:
      KOHNO Nobuoki
    • 依托单位:
    DEVELOPMENT OF A LUNG CANCER TREATMENT USING ANTI-KL-6/MUC1 MULTI-MONOCLONAL ANTIBODIES
    海外基金